Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

ACHV US Equity

Achieve Life Sciences, Inc.Health Care · In Vitro & In Vivo Diagnostic Substances · CIK 949858 · FY ends Dec 31
$8.53
+1.01 (+13.43%)
USD · as of 2026-08-19 · marketstack
3 8-K filings · 0 13D · 5 13G
DateEventWhat happened / filerSource
2026-08-1713GSchedule 13G filed — ≥5% beneficial owner (passive) · by Logos Global Management LPsec.gov ↗
2026-08-148-K 8.01Other eventssec.gov ↗
2026-08-1313GSchedule 13G filed — ≥5% beneficial owner (passive) · by Janus Henderson Group Ltd.sec.gov ↗
2026-08-118-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-2813G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by FRANKLIN RESOURCES INCsec.gov ↗
2026-07-2713GSchedule 13G filed — ≥5% beneficial owner (passive) · by BlackRock, Inc.sec.gov ↗
2026-07-0813GSchedule 13G filed — ≥5% beneficial owner (passive) · by Vivo Opportunity Fund Holdings, L.P.sec.gov ↗
2026-07-068-K 5.07Submission of matters to a vote of security holderssec.gov ↗
2026-07-068-K 5.03Amendments to articles of incorporation or bylaws; fiscal year changesec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-06

Every row is a filed document, checked against its EDGAR index.